MACK

Merrimack Pharmaceuticals, Inc.

Delisted

MACK was delisted on the 17th of May, 2024.

56 hedge funds and large institutions have $23.8M invested in Merrimack Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
-7
Holders Change %
-11.11%
% of All Funds
1.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
13
Reduced
22
Closed
14
Calls
Puts
$23K
Net Calls
-$23K
Net Calls Change
+$15K